Literature DB >> 17803658

Senile EBV-associated B-cell lymphoproliferative disorder of indolent clinical phenotype with recurrence as aggressive lymphoma.

Eisuke Shiozawa1, Bungo Saito, Toshiko Yamochi-Onizuka, Reiko Makino, Masafumi Takimoto, Tsuyoshi Nakamaki, Shigeru Tomoyasu, Hidekazu Ota.   

Abstract

Senile EBV-associated B-cell lymphoproliferative disorder (LPD) was proposed as a new disease entity in 2003. This condition has a high incidence in elderly people without underlying immunodeficiencies, and is characterized by EBV-positive B-cell proliferation with a polymorphic composition. Histologically, the disease has two subtypes. The polymorphic LPD (PLPD) subtype has a preferable prognosis, whereas the large cell lymphoma (LCL) subtype involves aggressive disease progression. Reported herein is a case of senile EBV-BLPD with indolent clinical features and PLPD subtype in the initial phase that recurred as an aggressive lymphoma 3 years after the initial diagnosis. In the recurrent phase, Southern blotting confirmed monoclonal proliferation of large lymphoid B-cells. In both the initial and recurrent phases, polymerase chain reaction (PCR) yielded a single discrete band of a similar size due to an immunoglobulin heavy-chain gene rearrangement, indicating that the large lymphoid B-cells retained identical monoclonality throughout the histological progression and over the whole clinical course. These results suggest that the PLPD subtype is a histological finding in early phase senile EBV-BLPD and that the LCL subtype reflects the progressive phase of the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17803658     DOI: 10.1111/j.1440-1827.2007.02158.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  3 in total

1.  Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma.

Authors:  Stefan D Dojcinov; Girish Venkataraman; Stefania Pittaluga; Iwona Wlodarska; Jeffrey A Schrager; Mark Raffeld; Robert K Hills; Elaine S Jaffe
Journal:  Blood       Date:  2011-03-08       Impact factor: 22.113

2.  A case of age-related EBV-associated B-cell lymphoproliferative disorder metachronously showing two distinct morphologic appearances, one of a polymorphic disease resembling classical Hodgkin lymphoma, and the other of a large-cell lymphoma.

Authors:  Tadashi Murase; Ayumi Fujita; Hironori Ueno; Jae-Won Park; Takahiro Yano; Masahiro Hoshikawa; Masayuki Takagi; Shigeru Kuramochi
Journal:  Int J Hematol       Date:  2008-12-18       Impact factor: 2.490

Review 3.  EBV-positive diffuse large B-cell lymphoma of the elderly.

Authors:  Chi Young Ok; Thomas G Papathomas; L Jeffrey Medeiros; Ken H Young
Journal:  Blood       Date:  2013-05-06       Impact factor: 22.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.